# Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

> **NCT06034197** · EARLY_PHASE1 · TERMINATED · sponsor: **Stephan Rogalla** · enrollment: 9 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** VGT-309

## Key facts

- **NCT ID:** NCT06034197
- **Lead sponsor:** Stephan Rogalla
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-07
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-04-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The drug supply expired and the sponsor is unable to provide an updated supply.
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034197, "Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06034197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*